Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: ChemMedChem. 2014 Apr 1;9(8):1677–1682. doi: 10.1002/cmdc.201402051

Figure 5.

Figure 5

Structure and pharmacological profile of (S)-16, ML381 (VU0480131). A) Structure and pharmacology of ML381. B) [3H]NMS competition binding [n = 3] in membranes prepared from human M5 cells, showing competitive displacement (Ki = 340 nM). C) CRCs of ML381 for human M5 (hM5 IC50 = 450 nM) and human M1-M4 (hM1-M4 IC50s >30 μM). D) CRCs of ML381 for rat M5 (rM5 IC50 = 1.65 μM) and rat M1-M4 (rM1-M4 IC50s >30 μM).